Knowledge HQ

Publications
Publications

Combined IL- 2, agonistic CD3 and 4- 1BB stimulation preserve clonotype hierarchy in propagated non- small cell lung cancer tumor- infiltrating lymphocytes

The study compares TIL expansion methods. TIL 3.0 (IL-2 + anti-CD3 + anti-4-1BB) in G-Rex expanded more TILs with better CD8+ enrichment and TCR diversity than standard IL-2. The REP phase also used GREX-10M.
Publications

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Describes a non-viral CRISPR/Cas9 method using ssCTS templates for high-yield CAR-T production. A GMP-compatible process was developed where cells were expanded in G-Rex 100M gas-permeable culture vessels for 7-10 days.
Publications

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma

This paper explores combining radiotherapy with CD98hc-targeted UniCAR T cells for HNSCC. The combo showed synergistic anti-tumor effects. Genetically modified T cells were seeded in 24-well G-Rex plates and expanded for 4–6 days.
Publications

Generation and proof- of- concept for allogeneic CD123 CAR- Delta One T (DOT) cells in acute myeloid leukemia

The study generates and validates allogeneic CD123 CAR-Delta One T (DOT) cells for AML. These cells showed potent cytotoxicity against AML lines and primary samples. DOT cells were generated from alpha-beta depleted PBMCs cultured in either 96-well plates or the G-REX platform.
Publications

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity

This study evaluates PRAME-specific TCR-Ts co-expressing a chimeric PD1-41BB receptor. These cells showed enhanced cytotoxicity against PRAME+ tumors in vitro and in vivo. G-Rex were used for the 10-day expansion phase of T-cells after transduction.
Publications

CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection

This study evaluates CAR/CXCR5-T cells for treating SIV infection in rhesus macaques. The cells homed to lymphoid follicles and reduced viral loads. Transduced T cells were expanded in G-Rex 500M-CS containers and 6-well plates during manufacturing.
Download Now
Publications

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants

SARS-CoV-2-specific T cells were generated from convalescent donors for adoptive immunotherapy. These cells recognized multiple viral variants and provided broad HLA coverage. G-Rex culture vessels were used to culture and expand the peptide-stimulated PBMCs.
Download Now
Publications

HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy

The HydrAd platform uses helper-dependent adenovirus (HDAd) vectors to express multiple immunomodulatory transgenes for cancer therapy. It was evaluated with T cells and NK cells. NK cells used in the study were expanded in G-Rex cell culture devices.
Download Now
Publications

High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA

A nonviral CRISPR/Cas9 method using plasmid donor DNA was developed for efficient gene knock-in in primary human T cells. The method was used for TCR and CAR integration. G-Rex 24-well plates were used to culture and expand the edited T cells.
Download Now
Publications

Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

This study identifies CISH as a negative regulator of T cell effector function. CRISPR/Cas9 deletion of CISH improved TIL neoantigen recognition and efficacy. Clinical-scale manufacturing of CISH KO TILs utilized G-Rex 100 for the rapid expansion protocol (REP).
Download Now
Publications

CB derived, optimized affinity CD38 CAR-NK cells with CD38 KO show promising in-vivo activity in a Multiple Myeloma model

This poster describes the development of cord blood-derived CD38 CAR-NK cells with CRISPR/Cas9-mediated CD38 knockout. These cells demonstrated potent activity against multiple myeloma. G-Rex 6M plates were utilized to achieve significant cell expansion (approx. 400-fold).
Publications

Robust In Vitro Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy

This study characterizes the pharmacology of the Tmod system, which uses an activator (CAR/TCR) and a blocker (LIR-1 based) to discriminate tumor from normal cells. Primary T cells transduced with Tmod constructs were cultured and recovered in G-Rex 24-well plates.
Download Now

ScaleReady is a joint venture between Wilson Wolf Manufacturing and Bio-Techne.